Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
2000 persons in the UK were examined serologically for antibodies to human T-lymphotropic virus type III (HTLV-III). Sera reacting in a membrane immunofluorescence assay (IFA) to HTLV-III were also positive when tested against cells infected with lymphadenopathy virus (LAV-1), and cross-adsorption tests indicated that these retroviruses are probably identical. A competitive radioimmunoassay (RIA), which was wholly concordant with IFA, was used to screen the sera. 30/31 patients with the acquired immunodeficiency syndrome (AIDS) were seropositive, as were 89% patients with persistent generalised lymphadenopathy (PGL), 17% symptomless homosexual men, 34% haemophiliacs receiving pooled clotting factors, and 1.5% intravenous drug abusers. None of more than 1000 unselected blood donors was seropositive. These data confirm the close association between HTLV-III and AIDS and PGL and show that infection with HTLV-III is also prevalent in the populations in whom these syndromes are most likely to develop. However, it would be unwise to presume that AIDS will necessarily develop in seropositive subjects.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000382:microbiology; D000914:Antibodies, Viral / Q000032:analysis*; D001782:Blood Donors; D017977:Deltaretrovirus / Q000276:immunology* / Q000302:isolation & purification; D006716:Homosexuality; D006801:Humans; D008206:Lymphatic Diseases / Q000276:immunology / Q000382:microbiology; D008297:Male; D011863:Radioimmunoassay; D012190:Retroviridae / Q000276:immunology; D012306:Risk; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology / Q000382:microbiology; D006113:United Kingdom
D000914:Antibodies, Viral